Showing 1 - 4 results of 4 for search 'Maryia Zhdanava', query time: 0.03s Refine Results
  1. 1
    Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States

    Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States by Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

    Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States by Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: